Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | GFER | P55789 | 1/20 | 0.55 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | MPL | P40238 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dobesilic Acid SCHEMBL232087 | 0.98 | LMNA (0.72) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL29389625 | 0.98 | LMNA (0.72) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL344443 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL214799 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL9790423 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL15364076 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL370202 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL78222 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL866670 | 0.95 | LMNA (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 | |
| Dobesilic Acid SCHEMBL10589964 | 0.95 | HSD17B10 (0.70) | LMNAHSD17B10HPGDHIF1APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663823-A1 | METHOD FOR PREPARING POLYESTER FIBER UNEASY TO PRODUCE MICROPLASTICS DURING USE | Jiangsu Hengli Chemical Fibre Co., Ltd. (CN) | 2025-12-17 | — | — | EP | claimed |
| CN-119008080-A | Preparation method and application of conductive paste for carbon-coated aluminum foil | 广东莱尔新材料科技股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024164573-A1 | METHOD FOR PREPARING POLYESTER FIBER UNEASY TO PRODUCE MICROPLASTICS DURING USE | 江苏恒力化纤股份有限公司 | 2024-08-15 | — | — | WO | claimed |
| WO-2024164576-A1 | PREPARATION METHOD FOR HIGH-STRENGTH BIODEGRADABLE POLYESTER FIBER | 江苏恒力化纤股份有限公司 | 2024-08-15 | — | — | WO | claimed |
| WO-2024164578-A1 | PREPARATION OF IONIC COPOLYMERIZED FLAME-RETARDANT POLYESTER MASTERBATCH AND USE IN FIBERS | 江苏恒力化纤股份有限公司 | 2024-08-15 | — | — | WO | claimed |
| WO-2024164575-A1 | IONIC POLYESTER MASTERBATCH CARRIER AND PREPARATION METHOD THEREFOR | 江苏恒力化纤股份有限公司 | 2024-08-15 | — | — | WO | claimed |
| CN-118213584-A | Sodium lignin sulfonate doped sulfonated polyarylether nitrile proton exchange membrane and preparation method thereof | 成都欧赛医疗器械有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117384463-B | Carbon fiber reinforced sulfonated PEEK composite material and preparation method thereof | 季华实验室 | 2024-03-08 | — | — | CN | claimed |
| CN-117089096-B | Preparation method of flame-retardant anti-dripping polyester film | 江苏恒力化纤股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117384463-A | Carbon fiber reinforced sulfonated PEEK composite material and preparation method thereof | 季华实验室 | 2024-01-12 | — | — | CN | claimed |
| WO-2008020037-A1 | USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING OBESITY, HIRSUTISM, HYPERTRICOSIS AND VIRAL WARTS | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| WO-2008020034-A1 | USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF HEMANGIOMAS OR HEMANGIOBLASTOMAS | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| WO-2008020042-A1 | USE OF 2, 5-DIHYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF TISSUE REACTIVE DISEASES | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| WO-2008020025-A1 | USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING ACTINIC KERATOSIS | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| US-20070149618-A1 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis | ACTION MEDICINES, S.L. | 2007-06-28 | — | — | US | claimed |
| US-6913694-B2 | Selective membrane having a high fouling resistance | SAEHAN INDUSTRIES INCORPORATION (KR) | 2005-07-05 | — | — | US | claimed |
| US-20030121844-A1 | Selective membrane having a high fouling resistance | SAEHAN INDUSTRIES INCORPORATION (KR) | 2003-07-03 | — | — | US | claimed |
| EP-0297916-B1 | CONTROL OF CORROSION IN AQUEOUS SYSTEMS | W.R. Grace & Co.-Conn. (US) | 1992-05-13 | — | — | EP | claimed |
| US-4847001-A | DIHYDROXYBENZENE SULFONIC ACIDS AND SALTS | W. R. GRACE & CO.-CONN. (US) | 1989-07-11 | — | — | US | claimed |
| EP-0297916-A1 | Control of corrosion in aqueous systems | W.R. Grace & Co.-Conn. (US) | 1989-01-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149618-A1 | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis | IL2, IL2RA, IL5 | LMNA 4181/4885HSD17B10 1497/4885HPGD 2149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.